» Articles » PMID: 2922288

AP-1/jun Binding Sites Mediate Serum Inducibility of the Human Vimentin Promoter

Overview
Specialty Biochemistry
Date 1989 Feb 25
PMID 2922288
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The vimentin gene is inducible by serum in quiescent Balb/c 3T3 cells, but the molecular mechanism of this induction is unknown. The results presented here represent a first step towards the elucidation of the pathway of events leading from growth factor-receptor interaction to this induction. A series of Bal 31 deletions of the human vimentin promoter are used to show that a sequence residing at -700 is responsible for the serum, and also TPA inducibility of this gene. This sequence is able to confer serum inducibility upon uninducible constructs regardless of its position and orientation, indicating that it is this element alone which is required for this induction. The isolated sequence is a strong enhancer as well. Further deletions and the use of synthetic oligonucleotides demonstrate that a 24-mer containing two AP-1/jun binding sites confer both serum and TPA inducibility upon the human vimentin gene. Gel retardation analysis confirms that this sequence binds an AP-1 -like protein.

Citing Articles

Biomarker Potential of Vimentin in Oral Cancers.

Mogre S, Makani V, Pradhan S, Devre P, More S, Vaidya M Life (Basel). 2022; 12(2).

PMID: 35207438 PMC: 8879320. DOI: 10.3390/life12020150.


Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis.

Usman S, Waseem N, Nguyen T, Mohsin S, Jamal A, Teh M Cancers (Basel). 2021; 13(19).

PMID: 34638469 PMC: 8507690. DOI: 10.3390/cancers13194985.


Vimentin Intermediate Filaments as Potential Target for Cancer Treatment.

Strouhalova K, Prechova M, Gandalovicova A, Brabek J, Gregor M, Rosel D Cancers (Basel). 2020; 12(1).

PMID: 31940801 PMC: 7017239. DOI: 10.3390/cancers12010184.


Vimentin on the move: new developments in cell migration.

Battaglia R, Delic S, Herrmann H, Snider N F1000Res. 2018; 7.

PMID: 30505430 PMC: 6241562. DOI: 10.12688/f1000research.15967.1.


as a Potential Metastasis Suppressor Gene in Human Colorectal Cancer.

Suk F, Chang C, Lin R, Lin S, Chen Y, Liang Y Int J Mol Sci. 2018; 19(5).

PMID: 29751537 PMC: 5983627. DOI: 10.3390/ijms19051350.


References
1.
Siebert P, Fukuda M . Induction of cytoskeletal vimentin and actin gene expression by a tumor-promoting phorbol ester in the human leukemic cell line K562. J Biol Chem. 1985; 260(6):3868-74. View

2.
Muller R, Bravo R, Burckhardt J, Curran T . Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature. 1984; 312(5996):716-20. DOI: 10.1038/312716a0. View

3.
Rittling S, Gibson C, Ferrari S, Baserga R . The effect of cycloheximide on the expression of cell cycle dependent genes. Biochem Biophys Res Commun. 1985; 132(1):327-35. DOI: 10.1016/0006-291x(85)91026-5. View

4.
Deschamps J, Meijlink F, Verma I . Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. Science. 1985; 230(4730):1174-7. DOI: 10.1126/science.3865371. View

5.
Rittling S, Brooks K, Cristofalo V, Baserga R . Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts. Proc Natl Acad Sci U S A. 1986; 83(10):3316-20. PMC: 323504. DOI: 10.1073/pnas.83.10.3316. View